{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:25:09Z","timestamp":1793381109922,"version":"4.5.0"},"reference-count":318,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N009851\/1"],"award-info":[{"award-number":["MR\/N009851\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T014644\/1"],"award-info":[{"award-number":["MR\/T014644\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/L01405X\/1"],"award-info":[{"award-number":["BB\/L01405X\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C20953\/A18644"],"award-info":[{"award-number":["C20953\/A18644"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>NF-E2 p45-related factor 2 (NRF2, encoded in the human by NFE2L2) mediates short-term adaptation to thiol-reactive stressors. In normal cells, activation of NRF2 by a thiol-reactive stressor helps prevent, for a limited period of time, the initiation of cancer by chemical carcinogens through induction of genes encoding drug-metabolising enzymes. However, in many tumour types, NRF2 is permanently upregulated. In such cases, its overexpressed target genes support the promotion and progression of cancer by suppressing oxidative stress, because they constitutively increase the capacity to scavenge reactive oxygen species (ROS), and they support cell proliferation by increasing ribonucleotide synthesis, serine biosynthesis and autophagy. Herein, we describe cancer chemoprevention and the discovery of the essential role played by NRF2 in orchestrating protection against chemical carcinogenesis. We similarly describe the discoveries of somatic mutations in NFE2L2 and the gene encoding the principal NRF2 repressor, Kelch-like ECH-associated protein 1 (KEAP1) along with that encoding a component of the E3 ubiquitin-ligase complex Cullin 3 (CUL3), which result in permanent activation of NRF2, and the recognition that such mutations occur frequently in many types of cancer. Notably, mutations in NFE2L2, KEAP1 and CUL3 that cause persistent upregulation of NRF2 often co-exist with mutations that activate KRAS and the PI3K-PKB\/Akt pathway, suggesting NRF2 supports growth of tumours in which KRAS or PKB\/Akt are hyperactive. Besides somatic mutations, NRF2 activation in human tumours can occur by other means, such as alternative splicing that results in a NRF2 protein which lacks the KEAP1-binding domain or overexpression of other KEAP1-binding partners that compete with NRF2. Lastly, as NRF2 upregulation is associated with resistance to cancer chemotherapy and radiotherapy, we describe strategies that might be employed to suppress growth and overcome drug resistance in tumours with overactive NRF2.<\/jats:p>","DOI":"10.3390\/cancers12123609","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T20:25:49Z","timestamp":1606940749000},"page":"3609","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of Tumourigenesis"],"prefix":"10.3390","volume":"12","author":[{"given":"Holly","family":"Robertson","sequence":"first","affiliation":[{"name":"Jacqui Wood Cancer Centre, Division of Cellular Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, UK"},{"name":"Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albena T.","family":"Dinkova-Kostova","sequence":"additional","affiliation":[{"name":"Jacqui Wood Cancer Centre, Division of Cellular Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Hayes","sequence":"additional","affiliation":[{"name":"Jacqui Wood Cancer Centre, Division of Cellular Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","article-title":"NRF2 and the Hallmarks of Cancer","volume":"34","author":"Chapman","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1152\/ajpregu.00327.2006","article-title":"An integrated view of oxidative stress in aging: Basic mechanisms, functional effects, and pathological considerations","volume":"292","author":"Kregel","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/gerona\/glx177","article-title":"Nrf2 Deficiency Exacerbates Obesity-Induced Oxidative Stress, Neurovascular Dysfunction, Blood-Brain Barrier Disruption, Neuroinflammation, Amyloidogenic Gene Expression, and Cognitive Decline in Mice, Mimicking the Aging Phenotype","volume":"73","author":"Tarantini","year":"2018","journal-title":"J. Gerontol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.14336\/AD.2018.0513","article-title":"The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1\/Nrf2\/ARE Signaling Pathway in Chronic Diseases","volume":"10","author":"Tu","year":"2019","journal-title":"Aging Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.1073\/pnas.91.21.9926","article-title":"Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2\/AP1 repeat of the beta-globin locus control region","volume":"91","author":"Moi","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"13943","DOI":"10.1073\/pnas.93.24.13943","article-title":"NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development","volume":"93","author":"Chan","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative Stress in Cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"11632","DOI":"10.1016\/S0021-9258(18)99004-6","article-title":"The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity","volume":"266","author":"Rushmore","year":"1991","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1073\/pnas.89.2.668","article-title":"Two adjacent AP-1-like binding sites form the electrophile-responsive element of the murine glutathione S-transferase Ya subunit gene","volume":"89","author":"Friling","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","first-page":"7581","article-title":"MafB, a new Maf family transcription activator that can associate with Maf and Fos but not with Jun","volume":"14","author":"Kataoka","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1128\/MCB.15.8.4184","article-title":"Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins","volume":"15","author":"Itoh","year":"1995","journal-title":"J. Mol. Cell. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8044","DOI":"10.1128\/MCB.25.18.8044-8051.2005","article-title":"Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes","volume":"25","author":"Katsuoka","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1042\/bst0280033","article-title":"The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin","volume":"28","author":"Hayes","year":"2000","journal-title":"Biochem. Soc. Trans."},{"key":"ref_16","first-page":"3299","article-title":"The Cap \u2018n\u2019 Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes","volume":"61","author":"McMahon","year":"2001","journal-title":"Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1073\/pnas.051618798","article-title":"Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice","volume":"98","author":"Kwak","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/bj20020320","article-title":"Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice","volume":"365","author":"Chanas","year":"2002","journal-title":"Biochem. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1073\/pnas.112203099","article-title":"Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors","volume":"99","author":"Fahey","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/1535-7163.MCT-06-0516","article-title":"Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes","volume":"6","author":"Yates","year":"2007","journal-title":"Mol. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"33747","DOI":"10.1074\/jbc.M110.163485","article-title":"An exceptionally potent inducer of cytoprotective enzymes: Elucidation of the structural features that determine inducer potency and reactivity with Keap1","volume":"285","author":"Talalay","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1074\/jbc.M211898200","article-title":"Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival","volume":"278","author":"Kwak","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"16023","DOI":"10.1074\/jbc.275.21.16023","article-title":"Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages","volume":"275","author":"Ishii","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_24","first-page":"5196","article-title":"Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray","volume":"62","author":"Thimmulappa","year":"2002","journal-title":"Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10059-009-0050-y","article-title":"Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin","volume":"27","author":"Soriano","year":"2009","journal-title":"Mol. Cells"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10549-011-1536-9","article-title":"Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles","volume":"132","author":"Agyeman","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s42255-019-0063-6","article-title":"Nrf2 controls iron homeostasis in haemochromatosis and thalassaemia via Bmp6 and hepcidin","volume":"1","author":"Lim","year":"2019","journal-title":"Nat. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1093\/nar\/gkq212","article-title":"Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis","volume":"38","author":"Malhotra","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/toxsci\/kfr183","article-title":"Beneficial role of Nrf2 in regulating NADPH generation and consumption","volume":"123","author":"Wu","year":"2011","journal-title":"Toxicol. Sci. Off. J. Soc. Toxicol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1093\/nar\/gks409","article-title":"Identification of novel NRF2-regulated genes by ChIP-Seq: Influence on retinoid X receptor alpha","volume":"40","author":"Chorley","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","article-title":"Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming","volume":"22","author":"Mitsuishi","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.taap.2009.03.005","article-title":"Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents","volume":"237","author":"Higgins","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.06.004","article-title":"Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elements","volume":"477","author":"Maruyama","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"78ra32","DOI":"10.1126\/scitranslmed.3002042","article-title":"Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model","volume":"3","author":"Harvey","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1080\/15548627.2016.1208889","article-title":"Transcription factor NFE2L2\/NRF2 is a regulator of macroautophagy genes","volume":"12","author":"Pajares","year":"2016","journal-title":"Autophagy"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.devcel.2019.07.010","article-title":"Cancer Cells Upregulate NRF2 Signaling to Adapt to Autophagy Inhibition","volume":"50","author":"Towers","year":"2019","journal-title":"Dev. Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1167\/iovs.10-5775","article-title":"Transcriptional Regulation of Activating Transcription Factor 4 under Oxidative Stress in Retinal Pigment Epithelial ARPE-19\/HPV-16 Cells","volume":"52","author":"Miyamoto","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/jid.2014.77","article-title":"The oncogene ATF3 is potentiated by cyclosporine A and ultraviolet light A","volume":"134","author":"Dziunycz","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ccell.2018.05.001","article-title":"Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance","volume":"33","author":"Takahashi","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2015.05.017","article-title":"Crosstalk between Nrf2 and Notch signaling","volume":"88","author":"Wakabayashi","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"13896","DOI":"10.1038\/s41598-019-50356-0","article-title":"NRF2-dependent gene expression promotes ciliogenesis and Hedgehog signaling","volume":"9","author":"Blanco","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Liu, P., Dodson, M., Fang, D., Chapman, E., and Zhang, D.D. (2020). NRF2 negatively regulates primary ciliogenesis and hedgehog signaling. PLoS Biol., 18.","DOI":"10.1371\/journal.pbio.3000620"},{"key":"ref_44","first-page":"1","article-title":"Chemoprevention of cancer","volume":"45","author":"Wattenberg","year":"1985","journal-title":"Cancer Res."},{"key":"ref_45","first-page":"1520","article-title":"Chemoprophylaxis of carcinogenesis: A review","volume":"26","author":"Wattenberg","year":"1966","journal-title":"Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/path.1700400312","article-title":"Experimental inhibition of tumour induction by mustard gas and other compounds","volume":"40","author":"Berenblum","year":"1935","journal-title":"J. Pathol. Bacteriol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/path.1700340604","article-title":"The anti-carcinogenic action of dichlorodiethylsulphide (mustard gas)","volume":"34","author":"Berenblum","year":"1931","journal-title":"J. Pathol. Bacteriol."},{"key":"ref_48","first-page":"346","article-title":"Influence of Unsaturated Dibasic Acids on the Induction of Skin Tumors by Chemical Carcinogens","volume":"5","author":"Crabtree","year":"1945","journal-title":"Cancer Res."},{"key":"ref_49","first-page":"39","article-title":"Retardation of the Rate of Tumor Induction by Hydrolyzing Chlor-Compounds","volume":"1","author":"Crabtree","year":"1941","journal-title":"Cancer Res."},{"key":"ref_50","first-page":"356","article-title":"Liver tumor inhibition and adrenal histologic responses in rats to which 3\u2032-methyl-4-dimethylaminoazobenzene and 20-methylcholanthrene were simultaneously administered","volume":"12","author":"Richardson","year":"1952","journal-title":"Cancer Res."},{"key":"ref_51","first-page":"802","article-title":"3-Methylcholanthrene as an inhibitor of hepatic cancer induced by 3\u2032-methyl-4-dimethylaminoazobenzene in the diet of the rat: A determination of the time relationships","volume":"13","author":"Meechan","year":"1953","journal-title":"Cancer Res."},{"key":"ref_52","first-page":"469","article-title":"On the protective action of certain polycyclic aromatic hydrocarbons against carcinogenesis by aminoazo dyes and 2-acetylaminofluorene","volume":"18","author":"Miller","year":"1958","journal-title":"Cancer Res."},{"key":"ref_53","first-page":"805","article-title":"Mechanisms of chemical carcinogenesis: Nature of proximate carcinogens and interactions with macromolecules","volume":"18","author":"Miller","year":"1966","journal-title":"Pharmacol. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1073\/pnas.73.10.3381","article-title":"Metabolism of benzo[a]pyrene: Conversion of (+\/\u2212)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to highly mutagenic 7,8-diol-9,10-epoxides","volume":"73","author":"Thakker","year":"1976","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1073\/pnas.73.11.3867","article-title":"(+\/\u2212)-trans-7,8-dihydroxy-7,8-dihydrobenzo (a)pyrene: A potent skin carcinogen when applied topically to mice","volume":"73","author":"Levin","year":"1976","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_56","first-page":"934","article-title":"Induction of increased benzpyrene hydroxylase activity by flavones and related compounds","volume":"28","author":"Wattenberg","year":"1968","journal-title":"Cancer Res."},{"key":"ref_57","first-page":"1922","article-title":"Inhibition of the carcinogenic action of benzo(a)pyrene by flavones","volume":"30","author":"Wattenberg","year":"1970","journal-title":"Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/carcin\/7.8.1379","article-title":"Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (Oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustard","volume":"7","author":"Wattenberg","year":"1986","journal-title":"Carcinogenesis"},{"key":"ref_59","first-page":"1425","article-title":"Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by phenolic antioxidants and ethoxyquin","volume":"48","author":"Wattenberg","year":"1972","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0015-6264(73)80486-9","article-title":"Antioxidants and carcinogenesis: Butylated hydroxytoluene, but not diphenyl-p-phenylenediamine, inhibits cancer induction by N-2-fluorenylacetamide and by N-hydroxy-N-2-fluorenylacetamide in rats","volume":"11","author":"Ulland","year":"1973","journal-title":"Food Cosmet. Toxicol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0278-6915(99)00085-X","article-title":"Safety assessment of butylated hydroxyanisole and butylated hydroxytoluene as antioxidant food additives","volume":"37","author":"Williams","year":"1999","journal-title":"Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/jnci\/52.5.1583","article-title":"Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by several sulfur-containing compounds","volume":"52","author":"Wattenberg","year":"1974","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_63","first-page":"1410","article-title":"Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles","volume":"38","author":"Wattenberg","year":"1978","journal-title":"Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0015-6264(73)80487-0","article-title":"Effect of the antioxidant butylated hydroxytoluene (BHT) on the metabolism of the carcinogens N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide","volume":"11","author":"Grantham","year":"1973","journal-title":"Food Cosmet. Toxicol."},{"key":"ref_65","first-page":"4496","article-title":"Enhancement of liver microsome epoxide hydratase activity in rodents by treatment with 2(3)-tert-butyl-4-hydroxyanisole","volume":"38","author":"Cha","year":"1978","journal-title":"Cancer Res."},{"key":"ref_66","first-page":"4486","article-title":"Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants","volume":"38","author":"Benson","year":"1978","journal-title":"Cancer Res."},{"key":"ref_67","first-page":"2971","article-title":"Elevation of extrahepatic glutathione S-transferase and epoxide hydratase activities by 2(3)-tert-butyl-4-hydroxyanisole","volume":"39","author":"Benson","year":"1979","journal-title":"Cancer Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1073\/pnas.77.9.5216","article-title":"Increase of NAD(P)H:quinone reductase by dietary antioxidants: Possible role in protection against carcinogenesis and toxicity","volume":"77","author":"Benson","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","first-page":"1205","article-title":"Enhancement of glutathione S-transferase activity of the esophagus by phenols, lactones, and benzyl isothiocyanate","volume":"42","author":"Sparnins","year":"1982","journal-title":"Cancer Res."},{"key":"ref_70","first-page":"493","article-title":"Glutathione S-transferase activity: Enhancement by compounds inhibiting chemical carcinogenesis and by dietary constituents","volume":"68","author":"Sparnins","year":"1982","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/bj2920013","article-title":"A novel aldehyde reductase with activity towards a metabolite of aflatoxin B1 is expressed in rat liver during carcinogenesis and following the administration of an anti-oxidant","volume":"292","author":"Judah","year":"1993","journal-title":"Biochem. J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"13324","DOI":"10.1016\/S0021-9258(18)37708-1","article-title":"Tissue-specific induction of murine glutathione transferase mRNAs by butylated hydroxyanisole","volume":"263","author":"Pearson","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0021-9258(18)33096-5","article-title":"Increased synthesis of glutathione S-transferases in response to anticarcinogenic antioxidants. Cloning and measurement of messenger RNA","volume":"258","author":"Pearson","year":"1983","journal-title":"J. Biol. Chem."},{"key":"ref_74","first-page":"2609","article-title":"Comparative effects of dietary administration of 2(3)-tert-butyl-4-hydroxyanisole and 3,5-di-tert-butyl-4-hydroxytoluene on several hepatic enzyme activities in mice and rats","volume":"42","author":"Cha","year":"1982","journal-title":"Cancer Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/carcin\/5.6.841","article-title":"Induction of hepatic glutathione S-transferase activity by butylated hydroxyanisole and conjugation of benzo[a]pyrene diol-epoxide","volume":"5","author":"Dock","year":"1984","journal-title":"Carcinogenesis"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1021\/tx500298n","article-title":"Human aldo-keto reductases and the metabolic activation of polycyclic aromatic hydrocarbons","volume":"27","author":"Penning","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"ref_77","first-page":"236","article-title":"Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: A review","volume":"29","author":"Newberne","year":"1969","journal-title":"Cancer Res."},{"key":"ref_78","first-page":"3924","article-title":"Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: Role of induction of glutathione S-transferases","volume":"46","author":"Kensler","year":"1986","journal-title":"Cancer Res."},{"key":"ref_79","first-page":"4271","article-title":"Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones","volume":"47","author":"Kensler","year":"1987","journal-title":"Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1042\/bj2790385","article-title":"Ethoxyquin-induced resistance to aflatoxin B1 in the rat is associated with the expression of a novel alpha-class glutathione S-transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide","volume":"279","author":"Hayes","year":"1991","journal-title":"Biochem. J."},{"key":"ref_81","first-page":"3887","article-title":"Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin","volume":"53","author":"Hayes","year":"1993","journal-title":"Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"10350","DOI":"10.1073\/pnas.90.21.10350","article-title":"An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductases","volume":"90","author":"Ellis","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1021\/bi962537o","article-title":"Conjugation of highly reactive aflatoxin B1 exo-8,9-epoxide catalyzed by rat and human glutathione transferases: Estimation of kinetic parameters","volume":"36","author":"Johnson","year":"1997","journal-title":"Biochemistry"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0009-2797(97)00151-8","article-title":"Regulation of rat glutathione S-transferase A5 by cancer chemopreventive agents: Mechanisms of inducible resistance to aflatoxin B1","volume":"111\u2013112","author":"Hayes","year":"1998","journal-title":"Chem.-Biol. Interact."},{"key":"ref_85","first-page":"957","article-title":"Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver","volume":"60","author":"Kelly","year":"2000","journal-title":"Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1021\/tx010005p","article-title":"Reduction of aflatoxin B1 dialdehyde by rat and human aldo-keto reductases","volume":"14","author":"Guengerich","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1042\/bj2850173","article-title":"Molecular cloning and heterologous expression of a cDNA encoding a mouse glutathione S-transferase Yc subunit possessing high catalytic activity for aflatoxin B1-8,9-epoxide","volume":"285","author":"Hayes","year":"1992","journal-title":"Biochem. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/carcin\/bgx048","article-title":"Characterization of liver injury, oval cell proliferation and cholangiocarcinogenesis in glutathione S-transferase A3 knockout mice","volume":"38","author":"Crawford","year":"2017","journal-title":"Carcinogenesis"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00204-011-0675-4","article-title":"Nrf2: Control of sensitivity to carcinogens","volume":"85","author":"Slocum","year":"2011","journal-title":"Arch. Toxicol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/toxsci\/kfw065","article-title":"Generation of a New Model Rat: Nrf2 Knockout Rats Are Sensitive to Aflatoxin B1 Toxicity","volume":"152","author":"Taguchi","year":"2016","journal-title":"Toxicol. Sci. Off. J. Soc. Toxicol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1158\/0008-5472.CAN-04-1906","article-title":"Nrf2 Is Essential for the Chemopreventive Efficacy of Oltipraz against Urinary Bladder Carcinogenesis","volume":"64","author":"Iida","year":"2004","journal-title":"Cancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1158\/0008-5472.CAN-06-0300","article-title":"Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL\/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2","volume":"66","author":"Xu","year":"2006","journal-title":"Cancer Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canlet.2005.05.007","article-title":"Sulforaphane prevents mouse skin tumorigenesis during the stage of promotion","volume":"236","author":"Gills","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.canlet.2005.09.012","article-title":"Protection against UV-light-induced skin carcinogenesis in SKH-1 high-risk mice by sulforaphane-containing broccoli sprout extracts","volume":"240","author":"Jenkins","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_95","first-page":"597","article-title":"Dietary glucoraphanin-rich broccoli sprout extracts protect against UV radiation-induced skin carcinogenesis in SKH-1 hairless mice","volume":"9","author":"Fahey","year":"2010","journal-title":"Photochem. Photobiol. Sci. Off. J. Eur. Photochem. Assoc. Eur. Soc. Photobiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1158\/1940-6207.CAPR-14-0359","article-title":"Nrf2-dependent suppression of azoxymethane\/dextran sulfate sodium-induced colon carcinogenesis by the cinnamon-derived dietary factor cinnamaldehyde","volume":"8","author":"Long","year":"2015","journal-title":"Cancer Prev. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"53502","DOI":"10.18632\/oncotarget.10609","article-title":"Chemoprevention of oxidative stress-associated oral carcinogenesis by sulforaphane depends on NRF2 and the isothiocyanate moiety","volume":"7","author":"Lan","year":"2016","journal-title":"Oncotarget"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1158\/1940-6207.CAPR-12-0401-T","article-title":"Roles of Keap1-Nrf2 system in upper aerodigestive tract carcinogenesis","volume":"6","author":"Ohkoshi","year":"2013","journal-title":"Cancer Prev. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1073\/pnas.91.8.3147","article-title":"Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates","volume":"91","author":"Zhang","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Becks, L., Prince, M., Burson, H., Christophe, C., Broadway, M., Itoh, K., Yamamoto, M., Mathis, M., Orchard, E., and Shi, R. (2010). Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-540"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pharep.2015.08.014","article-title":"Chemopreventive effect of chrysin, a dietary flavone against benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice","volume":"68","author":"Kasala","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/ars.2014.6074","article-title":"A Curcumin Derivative That Inhibits Vinyl Carbamate-Induced Lung Carcinogenesis via Activation of the Nrf2 Protective Response","volume":"23","author":"Shen","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1158\/0008-5472.CAN-12-4499","article-title":"Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis","volume":"73","author":"Satoh","year":"2013","journal-title":"Cancer Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1089\/ars.2017.7201","article-title":"Identification of an Unfavorable Immune Signature in Advanced Lung Tumors from Nrf2-Deficient Mice","volume":"29","author":"Zhang","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1158\/0008-5472.CAN-15-1584","article-title":"NRF2 Intensifies Host Defense Systems to Prevent Lung Carcinogenesis, but After Tumor Initiation Accelerates Malignant Cell Growth","volume":"76","author":"Satoh","year":"2016","journal-title":"Cancer Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/mc.22745","article-title":"The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer","volume":"57","author":"Tao","year":"2018","journal-title":"Mol. Carcinog."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/1477-3163.98459","article-title":"Prolonged sulforaphane treatment does not enhance tumorigenesis in oncogenic K-ras and xenograft mouse models of lung cancer","volume":"11","author":"Kombairaju","year":"2012","journal-title":"J. Carcinog."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"305861","DOI":"10.1155\/2013\/305861","article-title":"Nrf2 protection against liver injury produced by various hepatotoxicants","volume":"2013","author":"Liu","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.freeradbiomed.2017.12.010","article-title":"Mkp-1 protects mice against toxin-induced liver damage by promoting the Nrf2 cytoprotective response","volume":"115","author":"Luo","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1158\/0008-5472.CAN-16-3538","article-title":"Nrf2 Mutagenic Activation Drives Hepatocarcinogenesis","volume":"77","author":"Ngo","year":"2017","journal-title":"Cancer Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"8232","DOI":"10.1073\/pnas.82.23.8232","article-title":"On the mechanisms of induction of cancer-protective enzymes: A unifying proposal","volume":"82","author":"Prochaska","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"8261","DOI":"10.1073\/pnas.85.21.8261","article-title":"Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis","volume":"85","author":"Talalay","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1073\/pnas.90.7.2965","article-title":"Chemical and molecular regulation of enzymes that detoxify carcinogens","volume":"90","author":"Prestera","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0065-230X(08)60848-9","article-title":"The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents","volume":"29","author":"Chasseaud","year":"1979","journal-title":"Adv. Cancer Res.."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3109\/03602538409029962","article-title":"Effects of modifying structure on electrophilic reactions with biological nucleophiles","volume":"15","author":"Coles","year":"1984","journal-title":"Drug Metab. Rev."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1042\/bj2730711","article-title":"The potency of inducers of NAD(P)H:(quinone-acceptor) oxidoreductase parallels their efficiency as substrates for glutathione transferases. Structural and electronic correlations","volume":"273","author":"Spencer","year":"1991","journal-title":"Biochem. J."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/10409239509083491","article-title":"The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance","volume":"30","author":"Hayes","year":"1995","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0065-2571(93)90024-8","article-title":"The electrophile counterattack response: Protection against neoplasia and toxicity","volume":"33","author":"Prestera","year":"1993","journal-title":"Adv. Enzym. Regul."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"54750","DOI":"10.1074\/jbc.M410073200","article-title":"Crystal structure of the Kelch domain of human Keap1","volume":"279","author":"Li","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/MCB.26.8.2887-2900.2006","article-title":"Keap1 recruits Neh2 through binding to ETGE and DLG motifs: Characterization of the two-site molecular recognition model","volume":"26","author":"Tong","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"24756","DOI":"10.1074\/jbc.M601119200","article-title":"Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a \u201ctethering\u201d mechanism: A two-site interaction model for the Nrf2-Keap1 complex","volume":"281","author":"McMahon","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1128\/MCB.00753-07","article-title":"Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response","volume":"27","author":"Tong","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1128\/MCB.01191-13","article-title":"Kinetic, thermodynamic, and structural characterizations of the association between Nrf2-DLGex degron and Keap1","volume":"34","author":"Fukutomi","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.tibs.2008.12.008","article-title":"NRF2 and KEAP1 mutations: Permanent activation of an adaptive response in cancer","volume":"34","author":"Hayes","year":"2009","journal-title":"Trends Biochem. Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"21592","DOI":"10.1074\/jbc.M300931200","article-title":"Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression","volume":"278","author":"McMahon","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","article-title":"Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2","volume":"24","author":"Kobayashi","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1128\/MCB.24.19.8477-8486.2004","article-title":"The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: Oxidative stress sensing by a Cul3-Keap1 ligase","volume":"24","author":"Cullinan","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"10941","DOI":"10.1128\/MCB.24.24.10941-10953.2004","article-title":"Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex","volume":"24","author":"Zhang","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/MCB.25.1.162-171.2005","article-title":"BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase","volume":"25","author":"Furukawa","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/gb-2011-12-4-220","article-title":"The cullin protein family","volume":"12","author":"Sarikas","year":"2011","journal-title":"Genome Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/MCB.26.1.221-229.2006","article-title":"Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1","volume":"26","author":"Kobayashi","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2015.06.021","article-title":"Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease","volume":"88","author":"Tebay","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"13561","DOI":"10.1073\/pnas.1121572109","article-title":"Keap1 degradation by autophagy for the maintenance of redox homeostasis","volume":"109","author":"Taguchi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"15259","DOI":"10.1073\/pnas.1305687110","article-title":"Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex","volume":"110","author":"Baird","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"11908","DOI":"10.1073\/pnas.172398899","article-title":"Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants","volume":"99","author":"Holtzclaw","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1073\/pnas.0307301101","article-title":"Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers","volume":"101","author":"Wakabayashi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"18838","DOI":"10.1073\/pnas.1007387107","article-title":"Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals","volume":"107","author":"McMahon","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/ars.2012.4944","article-title":"The gasotransmitter hydrogen sulfide induces nrf2-target genes by inactivating the keap1 ubiquitin ligase substrate adaptor through formation of a disulfide bond between cys-226 and cys-613","volume":"19","author":"Hourihan","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.celrep.2019.06.047","article-title":"Molecular Mechanism of Cellular Oxidative Stress Sensing by Keap1","volume":"28","author":"Suzuki","year":"2019","journal-title":"Cell Rep."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nchembio.2536","article-title":"A role for 2-Cys peroxiredoxins in facilitating cytosolic protein thiol oxidation","volume":"14","author":"Maurer","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.freeradbiomed.2012.08.001","article-title":"Peroxiredoxin 1 functions as a signal peroxidase to receive, transduce, and transmit peroxide signals in mammalian cells","volume":"53","author":"Jarvis","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nchembio.1695","article-title":"Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling","volume":"11","author":"Sobotta","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"10399","DOI":"10.1074\/jbc.M115.699850","article-title":"Oxidant-induced Interprotein Disulfide Formation in Cardiac Protein DJ-1 Occurs via an Interaction with Peroxiredoxin 2","volume":"291","author":"Cho","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_145","first-page":"5463","article-title":"Cellular biochemistry of the stepwise development of cancer with chemicals: G. H. A. Clowes memorial lecture","volume":"44","author":"Farber","year":"1984","journal-title":"Cancer Res."},{"key":"ref_146","first-page":"4313","article-title":"Glutathione-associated enzymes in anticancer drug resistance","volume":"54","author":"Tew","year":"1994","journal-title":"Cancer Res."},{"key":"ref_147","first-page":"2065","article-title":"Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors","volume":"4","author":"Siegel","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1476-4598-6-75","article-title":"Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells","volume":"6","author":"Seo","year":"2007","journal-title":"Mol. Cancer"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3109\/1354750X.2012.715672","article-title":"Glutathione levels in human tumors","volume":"17","author":"Gamcsik","year":"2012","journal-title":"Biomarkers"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Singh, A., Misra, V., Thimmulappa, R.K., Lee, H., Ames, S., Hoque, M.O., Herman, J.G., Baylin, S.B., Sidransky, D., and Gabrielson, E. (2006). Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med., 3.","DOI":"10.1371\/journal.pmed.0030420"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/0008-5472.CAN-07-5003","article-title":"Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth","volume":"68","author":"Ohta","year":"2008","journal-title":"Cancer Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"13568","DOI":"10.1073\/pnas.0806268105","article-title":"Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy","volume":"105","author":"Shibata","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.3564","article-title":"Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas","volume":"48","author":"Campbell","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature13176","article-title":"Identification of genomic alterations in oesophageal squamous cell cancer","volume":"509","author":"Song","year":"2014","journal-title":"Nature"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic Signaling Pathways in The Cancer Genome Atlas","volume":"173","author":"Mina","year":"2018","journal-title":"Cell"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Network (2015). Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature, 517, 576\u2013582.","DOI":"10.1038\/nature14129"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network (2014). Comprehensive molecular characterization of gastric adenocarcinoma. Nature, 513, 202\u2013209.","DOI":"10.1038\/nature13480"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network (2014). Comprehensive molecular characterization of urothelial bladder carcinoma. Nature, 507, 315\u2013322.","DOI":"10.1038\/nature12965"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Muzny","year":"2012","journal-title":"Nature"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.celrep.2016.08.010","article-title":"Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers","volume":"16","author":"Goldstein","year":"2016","journal-title":"Cell Rep."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.cell.2013.10.011","article-title":"Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome","volume":"155","author":"Davoli","year":"2013","journal-title":"Cell"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","article-title":"Comprehensive Characterization of Cancer Driver Genes and Mutations","volume":"173","author":"Bailey","year":"2018","journal-title":"Cell"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41588-019-0572-y","article-title":"Identification of cancer driver genes based on nucleotide context","volume":"52","author":"Dietlein","year":"2020","journal-title":"Nat. Genet."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature10189","article-title":"Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis","volume":"475","author":"DeNicola","year":"2011","journal-title":"Nature"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/carcin\/bgn095","article-title":"Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2","volume":"29","author":"Wang","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1158\/1541-7786.MCR-17-0232","article-title":"miR-432 Induces NRF2 Stabilization by Directly Targeting KEAP1","volume":"15","author":"Akdemir","year":"2017","journal-title":"Mol. Cancer Res. MCR"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s41419-019-2031-1","article-title":"MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3\u2019UTR and predicts poor survival in non-small cell lung cancer","volume":"10","author":"Duan","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Song, S., Nguyen, V., Schrank, T., Mulvaney, K., Walter, V., Wei, D., Orvis, T., Desai, N., Zhang, J., and Hayes, D.N. (2020). Loss of SWI\/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma. Mol. Cancer Res. MCR.","DOI":"10.1158\/1541-7786.MCR-20-0082"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2011.09.006","article-title":"Renal cyst formation in Fh1-deficient mice is independent of the Hif\/Phd pathway: Roles for fumarate in KEAP1 succination and Nrf2 signaling","volume":"20","author":"Adam","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ccr.2011.08.024","article-title":"An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma","volume":"20","author":"Ooi","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-018-0622-0","article-title":"A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling","volume":"562","author":"Bollong","year":"2018","journal-title":"Nature"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"e101964","DOI":"10.15252\/embj.2019101964","article-title":"GSTZ1-1 Deficiency Activates NRF2\/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone","volume":"38","author":"Yang","year":"2019","journal-title":"EMBO J."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ccell.2017.10.009","article-title":"Oncogene-Stimulated Congestion at the KEAP1 Stress Signaling Hub Allows Bypass of NRF2 and Induction of NRF2-Target Genes that Promote Tumor Survival","volume":"32","author":"Hayes","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1038\/s41388-019-0956-6","article-title":"Nrf2 and SQSTM1\/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma","volume":"38","author":"Leinonen","year":"2019","journal-title":"Oncogene"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"101425","DOI":"10.1016\/j.redox.2019.101425","article-title":"Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas","volume":"30","author":"Escoll","year":"2020","journal-title":"Redox Biol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1038\/oncsis.2017.65","article-title":"Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis","volume":"6","author":"Fan","year":"2017","journal-title":"Oncogenesis"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/jnci\/djy230","article-title":"Targeting IDH1-Mutated Malignancies with NRF2 Blockade","volume":"111","author":"Liu","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1128\/MCB.01591-09","article-title":"Genetic analysis of cytoprotective functions supported by graded expression of Keap1","volume":"30","author":"Taguchi","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ng1248","article-title":"Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation","volume":"35","author":"Wakabayashi","year":"2003","journal-title":"Nat. Genet."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2005.10.185","article-title":"Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity","volume":"339","author":"Okawa","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1038\/s41467-020-19593-0","article-title":"Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers","volume":"11","author":"Okazaki","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"e5504","DOI":"10.1002\/path.5504","article-title":"A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissue","volume":"252","author":"Bowman","year":"2020","journal-title":"J. Pathol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jhep.2020.01.023","article-title":"NRF2 activates growth factor genes and downstream AKT signaling to induce mouse and human hepatomegaly","volume":"72","author":"He","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/emmm.201303281","article-title":"Activation of Nrf2 in keratinocytes causes chloracne (MADISH)-like skin disease in mice","volume":"6","author":"Willrodt","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1158\/0008-5472.CAN-15-0614","article-title":"Nrf2 Activation Promotes Keratinocyte Survival during Early Skin Carcinogenesis via Metabolic Alterations","volume":"75","author":"Rolfs","year":"2015","journal-title":"Cancer Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s42255-020-0191-z","article-title":"NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism","volume":"2","author":"Fox","year":"2020","journal-title":"Nat. Metab."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.devcel.2018.06.012","article-title":"Nrf2-Mediated Fibroblast Reprogramming Drives Cellular Senescence by Targeting the Matrisome","volume":"46","author":"Hiebert","year":"2018","journal-title":"Dev. Cell"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"8171","DOI":"10.1074\/jbc.M109.031575","article-title":"Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts","volume":"285","author":"Kapeta","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1158\/0008-5472.CAN-19-2888","article-title":"Microenvironmental Activation of Nrf2 Restricts the Progression of Nrf2-Activated Malignant Tumors","volume":"80","author":"Hayashi","year":"2020","journal-title":"Cancer Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","article-title":"Tracking the Evolution of Non-Small-Cell Lung Cancer","volume":"376","author":"Wilson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/hep.26616","article-title":"MicroRNA\/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC)","volume":"59","author":"Petrelli","year":"2014","journal-title":"Hepatology"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.27790","article-title":"Nrf2, but not \u03b2-catenin, mutation represents an early event in rat hepatocarcinogenesis","volume":"62","author":"Zavattari","year":"2015","journal-title":"Hepatology"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"G419","DOI":"10.1152\/ajpgi.00296.2019","article-title":"Keap1 deletion accelerates mutant K-ras\/p53-driven cholangiocarcinoma","volume":"318","author":"Nabeshima","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nm.4407","article-title":"Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis","volume":"23","author":"Romero","year":"2017","journal-title":"Nat. Med."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cmet.2018.02.006","article-title":"Synergy between the KEAP1\/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment","volume":"27","author":"Best","year":"2018","journal-title":"Cell Metab."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The pentose phosphate pathway and cancer","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.aaw9872","article-title":"Cysteine depletion induces pancreatic tumor ferroptosis in mice","volume":"368","author":"Badgley","year":"2020","journal-title":"Science"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccell.2014.11.019","article-title":"Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression","volume":"27","author":"Harris","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature15726","article-title":"Oxidative stress inhibits distant metastasis by human melanoma cells","volume":"527","author":"Piskounova","year":"2015","journal-title":"Nature"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"12156","DOI":"10.1038\/ncomms12156","article-title":"ERR\u03b1 mediates metabolic adaptations driving lapatinib resistance in breast cancer","volume":"7","author":"Deblois","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1038\/s41467-019-12164-y","article-title":"Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma","volume":"10","author":"Best","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/ng.3421","article-title":"NRF2 regulates serine biosynthesis in non-small cell lung cancer","volume":"47","author":"DeNicola","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1101\/gad.225680.113","article-title":"The emerging role of the Nrf2-Keap1 signaling pathway in cancer","volume":"27","author":"Jaramillo","year":"2013","journal-title":"Genes Dev."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1101\/gad.2016211","article-title":"Autophagy-deficient mice develop multiple liver tumors","volume":"25","author":"Takamura","year":"2011","journal-title":"Genes Dev."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1101\/gad.283416.116","article-title":"Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells","volume":"30","author":"Guo","year":"2016","journal-title":"Genes Dev."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1101\/gad.287524.116","article-title":"Recent insights into the function of autophagy in cancer","volume":"30","author":"Amaravadi","year":"2016","journal-title":"Genes Dev."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cell.2016.09.030","article-title":"p62 in Cancer: Signaling Adaptor Beyond Autophagy","volume":"167","author":"Moscat","year":"2016","journal-title":"Cell"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ccell.2020.05.018","article-title":"PKC\u03bb\/\u03b9 Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression","volume":"38","author":"Kudo","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1038\/s41388-020-01477-8","article-title":"The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression","volume":"39","author":"Jessen","year":"2020","journal-title":"Oncogene"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1080\/15384101.2020.1806426","article-title":"Ferroptosis: A new unexpected chance to treat metastatic melanoma?","volume":"19","author":"Gagliardi","year":"2020","journal-title":"Cell Cycle"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev.pharmtox.47.120505.105337","article-title":"Aldo-keto reductases and bioactivation\/detoxication","volume":"47","author":"Jin","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4614-8778-4_5","article-title":"A personalized treatment for lung cancer: Molecular pathways, targeted therapies, and genomic characterization","volume":"799","author":"Hensing","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.12968\/bjon.2013.22.Sup17.S15","article-title":"Lung cancer: Needs assessment, treatment and therapies","volume":"22","author":"Evans","year":"2013","journal-title":"Br. J. Nurs."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12964-020-00568-z","article-title":"Loss-of-function mutations in KEAP1 drive lung cancer progression via KEAP1\/NRF2 pathway activation","volume":"18","author":"Gong","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s10020-020-00166-2","article-title":"An integrative investigation on significant mutations and their down-stream pathways in lung squamous cell carcinoma reveals CUL3\/KEAP1\/NRF2 relevant subtypes","volume":"26","author":"Liu","year":"2020","journal-title":"Mol. Med."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","author":"Collisson","year":"2014","journal-title":"Nature"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","author":"Hammerman","year":"2012","journal-title":"Nature"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1042\/BST20160001","article-title":"Mutational patterns in oncogenes and tumour suppressors","volume":"44","author":"Baeissa","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1158\/0008-5472.CAN-13-1655","article-title":"Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination","volume":"74","author":"Hast","year":"2014","journal-title":"Cancer Res."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.18632\/oncotarget.2834","article-title":"PIK3CA mutations in non-small cell lung cancer (NSCLC): Genetic heterogeneity, prognostic impact and incidence of prior malignancies","volume":"6","author":"Scheffler","year":"2015","journal-title":"Oncotarget"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3892\/ol.2013.1427","article-title":"Keap1 mutations in lung cancer patients","volume":"6","author":"Sasaki","year":"2013","journal-title":"Oncol. Lett."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H","article-title":"Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung","volume":"92","author":"Ahrendt","year":"2001","journal-title":"Cancer"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/0008-5472.CAN-18-2723","article-title":"NRF2 Activation in Cancer: From DNA to Protein","volume":"79","author":"Cloer","year":"2019","journal-title":"Cancer Res."},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Wimuttisuk, W., West, M., Davidge, B., Yu, K., Salomon, A., and Singer, J.D. (2014). Novel Cul3 binding proteins function to remodel E3 ligase complexes. BMC Cell Biol., 15.","DOI":"10.1186\/1471-2121-15-28"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/sj.emboj.7600186","article-title":"Cullin-based ubiquitin ligases: Cul3-BTB complexes join the family","volume":"23","author":"Pintard","year":"2004","journal-title":"EMBO J."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1158\/1078-0432.CCR-17-1841","article-title":"Effects of co-occurring Genomic alterations on outcomes in patients with KRAS-mutant non-\u201csmall cell lung cancer","volume":"24","author":"Arbour","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_230","first-page":"1881","article-title":"Mutations in the Antioxidant KEAP1\/NRF2 Pathway Define an Aggressive Subset of NSCLC Resistant to Conventional Treatments","volume":"14","author":"Nadal","year":"2019","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"ref_231","first-page":"375","article-title":"Importance of the Keap1-Nrf2 pathway in NSCLC: Is it a possible biomarker?","volume":"9","year":"2018","journal-title":"Biomed. Rep."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.3748\/wjg.v22.i7.2284","article-title":"Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing","volume":"22","author":"Sasaki","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/1759-7714.12640","article-title":"Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy","volume":"9","author":"Zhang","year":"2018","journal-title":"Thorac. Cancer"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature20805","article-title":"Integrated genomic characterization of oesophageal carcinoma","volume":"541","author":"Kim","year":"2017","journal-title":"Nature"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/ng.2935","article-title":"Genomic and molecular characterization of esophageal squamous cell carcinoma","volume":"46","author":"Lin","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/path.5021","article-title":"Nrf2 promotes oesophageal cancer cell proliferation via metabolic reprogramming and detoxification of reactive oxygen species","volume":"244","author":"Kitano","year":"2018","journal-title":"J. Pathol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/1759-7714.13326","article-title":"MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma","volume":"11","author":"Zuo","year":"2020","journal-title":"Thorac. Cancer"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"e00256","DOI":"10.1042\/BSR20150092","article-title":"Methylseleninic acid activates Keap1\/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells","volume":"35","author":"Liu","year":"2015","journal-title":"Biosci. Rep."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1593\/neo.11750","article-title":"NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer","volume":"13","author":"Shibata","year":"2011","journal-title":"Neoplasia"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/path.2653","article-title":"Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin","volume":"220","author":"Kim","year":"2010","journal-title":"J. Pathol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"763257","DOI":"10.1155\/2013\/763257","article-title":"Role of the Nrf2-ARE Pathway in Liver Diseases","volume":"2013","author":"Shin","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Haque, E., Karim, M.R., Salam Teeli, A., \u00c5\u0161miech, M., Leszczynski, P., Winiarczyk, D., Parvanov, E.D., Atanasov, A.G., and Taniguchi, H. (2020). Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155378"},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Raghunath, A., Sundarraj, K., Arfuso, F., Sethi, G., and Perumal, E. (2018). Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance. Cancers, 10.","DOI":"10.3390\/cancers10120481"},{"key":"ref_244","unstructured":"(2017). Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 169, 1327\u20131341.e23."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jhep.2018.05.010","article-title":"Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis","volume":"69","author":"Orru","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Guichard","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4161\/auto.25063","article-title":"Functions of autophagy in normal and diseased liver","volume":"9","author":"Czaja","year":"2013","journal-title":"Autophagy"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jhep.2014.06.033","article-title":"YAP activation is an early event and a potential therapeutic target in liver cancer development","volume":"61","author":"Perra","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1038\/s41467-018-07338-z","article-title":"Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap","volume":"9","author":"Lee","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.molcel.2013.08.003","article-title":"Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy","volume":"51","author":"Ichimura","year":"2013","journal-title":"Mol. Cell"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Orru, C., Perra, A., Kowalik, M.A., Rizzolio, S., Puliga, E., Cabras, L., Giordano, S., and Columbano, A. (2020). Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis. Cancers, 12.","DOI":"10.3390\/cancers12082305"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/hed.20430","article-title":"Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas","volume":"28","author":"Stacy","year":"2006","journal-title":"Head Neck"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12885-017-3907-z","article-title":"Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer","volume":"18","author":"Namani","year":"2018","journal-title":"BMC Cancer"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1159\/000493615","article-title":"Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2\/HO-1 Axis","volume":"49","author":"Liu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hed.23663","article-title":"Disruption of KEAP1\/CUL3\/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms: Association with poor prognosis in head and neck cancer","volume":"37","author":"Martinez","year":"2015","journal-title":"Head Neck"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/annonc\/mdv109","article-title":"Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing","volume":"26","author":"Chung","year":"2015","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.3892\/ol.2016.5269","article-title":"Elevated expression of Nrf2 mediates multidrug resistance in CD133+ head and neck squamous cell carcinoma stem cells","volume":"12","author":"Lu","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Kawasaki, Y., Ishigami, S., Arigami, T., Uenosono, Y., Yanagita, S., Uchikado, Y., Kita, Y., Nishizono, Y., Okumura, H., and Nakajo, A. (2015). Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1008-4"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","article-title":"The global burden of urinary bladder cancer: An update","volume":"38","author":"Richters","year":"2020","journal-title":"World J. Urol."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00432-014-1733-0","article-title":"Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients","volume":"140","author":"Reszka","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.eururo.2017.03.010","article-title":"Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset","volume":"72","author":"Choi","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1158\/1078-0432.CCR-14-1215","article-title":"Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise","volume":"21","author":"Kim","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/cas.14321","article-title":"p62 promotes bladder cancer cell growth by activating KEAP1\/NRF2-dependent antioxidative response","volume":"111","author":"Li","year":"2020","journal-title":"Cancer Sci."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"aba0443","DOI":"10.1126\/scisignal.aba0443","article-title":"GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma","volume":"13","author":"Hayashi","year":"2020","journal-title":"Sci. Sig."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1038\/cddis.2014.149","article-title":"Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: Involvement of TET-dependent DNA demethylation","volume":"5","author":"Kang","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_267","first-page":"1","article-title":"NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer","volume":"21","author":"Wu","year":"2020","journal-title":"Cancer Genet."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ccell.2017.12.004","article-title":"Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer","volume":"33","author":"Yaeger","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_269","doi-asserted-by":"crossref","unstructured":"Torrente, L., Maan, G., Oumkaltoum Rezig, A., Quinn, J., Jackson, A., Grilli, A., Casares, L., Zhang, Y., Kulesskiy, E., and Saarela, J. (2020). High NRF2 Levels Correlate with Poor Prognosis in Colorectal Cancer Patients and with Sensitivity to the Kinase Inhibitor AT9283 In Vitro. Biomolecules, 10.","DOI":"10.3390\/biom10101365"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2407-12-66","article-title":"Methylation of the KEAP1 gene promoter region in human colorectal cancer","volume":"12","author":"Hanada","year":"2012","journal-title":"BMC Cancer"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"33","DOI":"10.29252\/rbmb.9.1.33","article-title":"Evaluation of the Epigenetic Demethylation of NRF2, a Master Transcription Factor for Antioxidant Enzymes, in Colorectal Cancer","volume":"9","author":"Taheri","year":"2020","journal-title":"Rep. Biochem. Mol. Biol."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2016.12.048","article-title":"Redox signaling in the gastrointestinal tract","volume":"104","author":"Perez","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"14547","DOI":"10.1073\/pnas.0907539106","article-title":"Nitric oxide activation of Keap1\/Nrf2 signaling in human colon carcinoma cells","volume":"106","author":"Li","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_274","first-page":"1124","article-title":"Correlation of Nrf2, NQO1, MRP1, cmyc and p53 in colorectal cancer and their relationships to clinicopathologic features and survival","volume":"7","author":"Ji","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Gonzalez-Donquiles, C., Alonso-Molero, J., Fernandez-Villa, T., Vilorio-Marqu\u00e9s, L., Molina, A.J., and Mart\u00edn, V. (2017). The NRF2 transcription factor plays a dual role in colorectal cancer: A systematic review. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177549"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1039\/C9NP00061E","article-title":"The role of natural products in revealing NRF2 function","volume":"37","author":"Zhang","year":"2020","journal-title":"Nat. Prod. Rep."},{"key":"ref_277","doi-asserted-by":"crossref","unstructured":"Yang, Q., Deng, H., Xia, H., Xu, M., Pan, G., Mao, J., Tao, S., Yamanaka, K., and An, Y. (2019). High NF-E2-related factor 2 expression predicts poor prognosis in patients with lung cancer: A meta-analysis of cohort studies. Free Radic. Res., 1\u20139.","DOI":"10.1080\/10715762.2019.1642472"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/1871520617666171103112019","article-title":"Combined Evaluation of Expression of CXCR4 and Nrf2 as Prognostic Factor for Patients with Gastric Carcinoma","volume":"18","author":"Yu","year":"2018","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_279","doi-asserted-by":"crossref","unstructured":"Lee, K., Kim, S., Lee, Y., Lee, H., Lee, Y., Park, H., Nahm, J.H., Ahn, S., Yu, S.J., and Lee, K. (2020). The Clinicopathological and Prognostic Significance of Nrf2 and Keap1 Expression in Hepatocellular Carcinoma. Cancers, 12.","DOI":"10.3390\/cancers12082128"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bcp.2014.07.017","article-title":"Targeting antioxidants for cancer therapy","volume":"92","author":"Glasauer","year":"2014","journal-title":"Biochem. Pharm."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"8773","DOI":"10.1073\/pnas.1105941108","article-title":"Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress","volume":"108","author":"Shaw","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canlet.2018.09.004","article-title":"Targeting antioxidant enzymes as a radiosensitizing strategy","volume":"438","author":"Jiang","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"e28083","DOI":"10.7554\/eLife.28083","article-title":"Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer","volume":"6","author":"Sayin","year":"2017","journal-title":"eLife"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cmet.2019.11.012","article-title":"Activation of Oxidative Stress Response in Cancer Generates a Druggable Dependency on Exogenous Non-essential Amino Acids","volume":"31","author":"LeBoeuf","year":"2020","journal-title":"Cell Metab."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1073\/pnas.1014275108","article-title":"Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism","volume":"108","author":"Ren","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"19589","DOI":"10.1073\/pnas.0709483104","article-title":"Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha","volume":"104","author":"Wang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.freeradbiomed.2011.03.008","article-title":"Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2\/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs","volume":"50","author":"Tang","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/mc.21921","article-title":"Drug resistance associates with activation of Nrf2 in MCF-7\/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response","volume":"52","author":"Zhong","year":"2013","journal-title":"Mol. Carcinog."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1074\/mcp.M115.055509","article-title":"Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis","volume":"15","author":"Vartanian","year":"2016","journal-title":"Mol. Cell. Proteom. MCP"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.freeradbiomed.2012.05.038","article-title":"An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses","volume":"53","author":"Lee","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1021\/acschembio.6b00651","article-title":"Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors","volume":"11","author":"Singh","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2016.12.041","article-title":"Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation","volume":"103","author":"Tsuchida","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1038\/onc.2017.153","article-title":"A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer","volume":"36","author":"Choi","year":"2017","journal-title":"Oncogene"},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0891-5849(00)00310-5","article-title":"Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues","volume":"29","author":"Siegel","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/acs.accounts.5b00365","article-title":"Deoxynyboquinones as NQO1-Activated Cancer Therapeutics","volume":"48","author":"Parkinson","year":"2015","journal-title":"Acc. Chem. Res."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1016\/0006-2952(88)90336-X","article-title":"The nitroreductase enzyme in Walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2)","volume":"37","author":"Knox","year":"1988","journal-title":"Biochem. Pharm."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1016\/0006-2952(88)90335-8","article-title":"A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells","volume":"37","author":"Knox","year":"1988","journal-title":"Biochem. Pharm."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.1021\/bi00149a019","article-title":"Bioreductive activation of mitomycin C by DT-diaphorase","volume":"31","author":"Siegel","year":"1992","journal-title":"Biochemistry"},{"key":"ref_299","first-page":"7483","article-title":"Metabolism of mitomycin C by DT-diaphorase: Role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells","volume":"50","author":"Siegel","year":"1990","journal-title":"Cancer Res."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1074\/jbc.272.3.1437","article-title":"Molecular basis of the catalytic differences among DT-diaphorase of human, rat, and mouse","volume":"272","author":"Chen","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_301","first-page":"4179","article-title":"Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: A novel co-substrate-mediated antitumor prodrug therapy","volume":"60","author":"Knox","year":"2000","journal-title":"Cancer Res."},{"key":"ref_302","first-page":"3196","article-title":"Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases","volume":"54","author":"Beall","year":"1994","journal-title":"Cancer Res."},{"key":"ref_303","first-page":"499","article-title":"Nicotinamide adenine dinucleotide (phosphate): Quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: Quinone cytotoxicity and selectivity in human lung and breast cancer cell lines","volume":"48","author":"Beall","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/annonc\/mdq638","article-title":"Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1","volume":"22","author":"Danson","year":"2011","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00280-019-03812-7","article-title":"Inactivation of apaziquone by haematuria: Implications for the design of phase III clinical trials against non-muscle invasive bladder cancer","volume":"83","author":"Phillips","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3389\/fonc.2020.01575","article-title":"Targeting Base Excision Repair in Cancer: NQO1-Bioactivatable Drugs Improve Tumor Selectivity and Reduce Treatment Toxicity Through Radiosensitization of Human Cancer","volume":"10","author":"Starcher","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1074\/jbc.275.8.5416","article-title":"NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity","volume":"275","author":"Pink","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1158\/0008-5472.CAN-11-3135","article-title":"An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis","volume":"72","author":"Huang","year":"2012","journal-title":"Cancer Res."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"10006","DOI":"10.1158\/0008-5472.CAN-05-2029","article-title":"Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: Role of 17-AAG hydroquinone in heat shock protein 90 inhibition","volume":"65","author":"Guo","year":"2005","journal-title":"Cancer Res."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1124\/mol.106.025643","article-title":"The bioreduction of a series of benzoquinone ansamycins by NAD(P)H:quinone oxidoreductase 1 to more potent heat shock protein 90 inhibitors, the hydroquinone ansamycins","volume":"70","author":"Guo","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"ref_311","doi-asserted-by":"crossref","unstructured":"Baird, L., Suzuki, T., Takahashi, Y., Hishinuma, E., Saigusa, D., and Yamamoto, M. (2020). Geldanamycin-derived HSP90 Inhibitors are Synthetic Lethal with NRF2. Mol. Cell. Biol., 40.","DOI":"10.1128\/MCB.00377-20"},{"key":"ref_312","doi-asserted-by":"crossref","unstructured":"Baird, L., and Yamamoto, M. (2020). NRF2-dependent bioactivation of mitomycin C as a novel strategy to target KEAP1-NRF2 pathway activation in human cancer. Mol. Cell. Biol., in press.","DOI":"10.1128\/MCB.00473-20"},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nchem.1596","article-title":"Synthesis of 19-substituted geldanamycins with altered conformations and their binding to heat shock protein Hsp90","volume":"5","author":"Kitson","year":"2013","journal-title":"Nat. Chem."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/mol.113.090654","article-title":"19-substituted benzoquinone ansamycin heat shock protein-90 inhibitors: Biological activity and decreased off-target toxicity","volume":"85","author":"Chang","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13578-019-0314-y","article-title":"The single-cell sequencing: New developments and medical applications","volume":"9","author":"Tang","year":"2019","journal-title":"Cell Biosci."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s12276-018-0071-8","article-title":"Single-cell RNA sequencing technologies and bioinformatics pipelines","volume":"50","author":"Hwang","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-018-0461-z","article-title":"Accurate classification of BRCA1 variants with saturation genome editing","volume":"562","author":"Findlay","year":"2018","journal-title":"Nature"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/12\/3609\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:40:43Z","timestamp":1760179243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/12\/3609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,2]]},"references-count":318,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["cancers12123609"],"URL":"https:\/\/doi.org\/10.3390\/cancers12123609","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,2]]}}}